A Clinical Trial Evaluating SCB-219M in in Chemotherapy-induced Thrombocytopenia (CIT) (clinicaltrials.gov) - May 8, 2024 - P1 | N=76 | Recruiting | Sponsor: Sichuan Clover Biopharmaceuticals, Inc. | Trial completion date: Jun 2024 ➔ Jun 2025 | Trial primary completion date: Jun 2024 ➔ Jun 2025
Trial completion date • Trial primary completion date • Hematological Disorders • Thrombocytopenia
|